Injection Pen Market, By Product Type (Reusable and Disposable), By Therapy (Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, and Other), By End-user (Homecare Settings, Hospitals, and Other) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Trends, Analysis and Forecast till 2034

Injection Pen Market was valued at US$ 51.5 Billion in 2024 and is projected to grow at a CAGR of 10.50% to reach US$ 127.9Billion by 2034.

Injection pen is generally used for self-administration of well-kept-up multi-dose drug formulations which required on the basis of weight.  Injection pens are available in two different forms; disposable and reusable injection pens. Moreover, it is a ready-to-administer, as a prefilled medical device which helps to ease the drug for patients, healthcare providers, and caregivers.  Emerging technologies and latest development in injection pens such as automatic needle insertion and injection, safety needle device, smaller dosing abilities, and electronics are some factors contributing the significant growth in the global injection pen market. Global Injection Pen Market accounted for US$ 35.03 billion in 2020 and is estimated to be US$ 72.39 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Easy compensation and rising FDA approval for injection pen is a key factor driving the global market growth during the forecast period. For instance, Antares Pharma introduced Makena subcutaneous auto-injector in merged with AMAG Pharmaceuticals in 2015. This strategic collaboration is to lower the threat of preterm birth in women who have a past history of spontaneous preterm birth. Thus, it is expected to gain more share value to the global injection pen market during the forecast period. Further, rising prevalence of diseases such as diabetes, hepatitis, hemolytic disease, osteoporosis, rheumatoid arthritis (RA), hemophilia, anemia, multiple sclerosis (MS), reproductive health, and anti-thrombolytic therapy are major reason behind the huge demand of injection pen, which is probably going to increasing within the forecast period.

However, the presence of alternatives drug delivery approach for injection pen and poor compensation scenarios in developing countries may hamper the global injection pen market growth in the coming years.

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The global injection pen market has been segmented on the basis of product type, therapy, end user, and region.

The product type segment includes a reusable injection pen and disposable injection pen. Further, on the basis of therapy, the global injection pen market is fragmented into diabetes, fertility, osteoporosis, growth hormone therapy, and other. Moreover, the end-user segment includes home care settings, hospitals, and other.

Regional Insights:

Injection Pen Market accounted for US$ 17.75 billion in 2020 and is estimated to be US$ 96.66 billion by 2030 and is anticipated to register a CAGR of 18.7%. For detailed understanding of market dynamics, the Global Injection Pen Market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. North America dominates the market with a considerable market share in the injectable pen market due to high prevalence of diabetes and good reimbursement policies. Due to expanding population and adoption of modern technology while improving healthcare infrastructure, Asia-Pacific is predicted to grow at a rapid and profitable rate during the projection period.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Injection Pen Market report based on Product Type, Therapy, End User and Region.

Injection Pen Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Key players operating in the global injection pen market includes Sanofi, Owen Mumford Ltd, Pfizer, Novo Nordisk, Eli Lilly, Merck & co., Inc., Biocorp Production SA,AstraZeneca PLC, Ypsomed Holding AG, Becton, Wilhelm Haselmeier GmbH & Co. KG, Dickinson and Company (BD), F.Hoffman-La Roche Ltd, , and Novartis.

• Sanofi
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Owen Mumford Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Pfizer
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Novo Nordisk
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Eli Lilly
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Merck & co., Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Biocorp Production SA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• AstraZeneca PLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Ypsomed Holding AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance